Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 38 entries
Sorted by: Best Match Show Resources per page
Second-generation antipsychotic discontinuation in first episode psychosis: an updated review.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology

Miller BJ, Bodenheimer C, Crittenden K.
PMID: 23429653
Clin Psychopharmacol Neurosci. 2011 Aug;9(2):45-53. doi: 10.9758/cpn.2011.9.2.45. Epub 2011 Aug 31.

"All-causes discontinuation" refers to discontinuation of treatment for any reason, and medication adherence is an important component of this measure. Similar to our previous results, we found that almost 30% of patients with first-episode psychosis (FEP) discontinue medication in...

Cite
Miller BJ, Bodenheimer C, Crittenden K. Second-generation antipsychotic discontinuation in first episode psychosis: an updated review. Clin Psychopharmacol Neurosci. 2011;9(2):45-53doi: 10.9758/cpn.2011.9.2.45.
Miller, B. J., Bodenheimer, C., & Crittenden, K. (2011). Second-generation antipsychotic discontinuation in first episode psychosis: an updated review. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 9(2), 45-53. https://doi.org/10.9758/cpn.2011.9.2.45
Miller, Brian J, et al. "Second-generation antipsychotic discontinuation in first episode psychosis: an updated review." Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology vol. 9,2 (2011): 45-53. doi: https://doi.org/10.9758/cpn.2011.9.2.45
Miller BJ, Bodenheimer C, Crittenden K. Second-generation antipsychotic discontinuation in first episode psychosis: an updated review. Clin Psychopharmacol Neurosci. 2011 Aug;9(2):45-53. doi: 10.9758/cpn.2011.9.2.45. Epub 2011 Aug 31. PMID: 23429653; PMCID: PMC3569083.
Copy Download .nbib Format: NLM
PALESTINE, GREAT NATURAL LABORATORY OF THE EAST.

Science (New York, N.Y.)

Bodenheimer FS.
PMID: 17818942
Science. 1933 Nov 24;78(2030):477-9. doi: 10.1126/science.78.2030.477.

No abstract available.

Cite
Bodenheimer FS. PALESTINE, GREAT NATURAL LABORATORY OF THE EAST. Science. 1933;78(2030):477-9doi: 10.1126/science.78.2030.477.
Bodenheimer, F. S. (1933). PALESTINE, GREAT NATURAL LABORATORY OF THE EAST. Science (New York, N.Y.), 78(2030), 477-9. https://doi.org/10.1126/science.78.2030.477
Bodenheimer, F S. "PALESTINE, GREAT NATURAL LABORATORY OF THE EAST." Science (New York, N.Y.) vol. 78,2030 (1933): 477-9. doi: https://doi.org/10.1126/science.78.2030.477
Bodenheimer FS. PALESTINE, GREAT NATURAL LABORATORY OF THE EAST. Science. 1933 Nov 24;78(2030):477-9. doi: 10.1126/science.78.2030.477. PMID: 17818942.
Copy Download .nbib Format: NLM
Care management of patients with complex health care needs.

The Synthesis project. Research synthesis report

Berry-Millett R, Bodenheimer TS.
PMID: 22052205
Synth Proj Res Synth Rep. 2009 Dec;(19). doi: 52372. Epub 2009 Dec 16.

Patients with complex health care needs account for a high percentage of annual medical expenditures. Care management is a set of activities intended to improve patient care and reduce the need for medical services by helping patients and caregivers...

Cite
Berry-Millett R, Bodenheimer TS. Care management of patients with complex health care needs. Synth Proj Res Synth Rep. 2009;(19)doi: 52372.
Berry-Millett, R., & Bodenheimer, T. S. (2009). Care management of patients with complex health care needs. The Synthesis project. Research synthesis report, (19), . https://doi.org/52372
Berry-Millett, Rachel, and Bodenheimer, Thomas S. "Care management of patients with complex health care needs." The Synthesis project. Research synthesis report vol. ,19 (2009). doi: https://doi.org/52372
Berry-Millett R, Bodenheimer TS. Care management of patients with complex health care needs. Synth Proj Res Synth Rep. 2009 Dec;(19). doi: 52372. Epub 2009 Dec 16. PMID: 22052205.
Copy Download .nbib Format: NLM
[No title available]

Wilhelm Roux' Archiv fur Entwicklungsmechanik der Organismen

Bodenheimer FS.
PMID: 28354377
Wilhelm Roux Arch Entwickl Mech Org. 1932 Sep;126(3):554-574. doi: 10.1007/BF00573766.

No abstract available.

Cite
Bodenheimer FS. Über Regelmässigkeiten im Wachstum der Insekten : II. Das Gewichtswachstum. . Wilhelm Roux Arch Entwickl Mech Org. 1932;126(3):554-574doi: 10.1007/BF00573766.
Bodenheimer, F. S. (1932). Über Regelmässigkeiten im Wachstum der Insekten : II. Das Gewichtswachstum. . Wilhelm Roux' Archiv fur Entwicklungsmechanik der Organismen, 126(3), 554-574. https://doi.org/10.1007/BF00573766
Bodenheimer, F S. "Über Regelmässigkeiten im Wachstum der Insekten : II. Das Gewichtswachstum." . Wilhelm Roux' Archiv fur Entwicklungsmechanik der Organismen vol. 126,3 (1932): 554-574. doi: https://doi.org/10.1007/BF00573766
Bodenheimer FS. Über Regelmässigkeiten im Wachstum der Insekten : II. Das Gewichtswachstum. . Wilhelm Roux Arch Entwickl Mech Org. 1932 Sep;126(3):554-574. doi: 10.1007/BF00573766. German. PMID: 28354377.
Copy Download .nbib Format: NLM
Protection against Covid-19 by BNT162b2 Booster across Age Groups.

The New England journal of medicine

Bar-On YM, Goldberg Y, Mandel M, Bodenheimer O, Freedman L, Alroy-Preis S, Ash N, Huppert A, Milo R.
PMID: 34879188
N Engl J Med. 2021 Dec 08; doi: 10.1056/NEJMoa2115926. Epub 2021 Dec 08.

BACKGROUND: After promising initial results from the administration of a third (booster) dose of the BNT162b2 messenger RNA vaccine (Pfizer-BioNTech) to persons 60 years of age or older, the booster campaign in Israel was gradually expanded to persons in...

Cite
Bar-On YM, Goldberg Y, Mandel M, et al. Protection against Covid-19 by BNT162b2 Booster across Age Groups. N Engl J Med. 2021;doi: 10.1056/NEJMoa2115926.
Bar-On, Y. M., Goldberg, Y., Mandel, M., Bodenheimer, O., Freedman, L., Alroy-Preis, S., Ash, N., Huppert, A., & Milo, R. (2021). Protection against Covid-19 by BNT162b2 Booster across Age Groups. The New England journal of medicine, . https://doi.org/10.1056/NEJMoa2115926
Bar-On, Yinon M, et al. "Protection against Covid-19 by BNT162b2 Booster across Age Groups." The New England journal of medicine vol. (2021). doi: https://doi.org/10.1056/NEJMoa2115926
Bar-On YM, Goldberg Y, Mandel M, Bodenheimer O, Freedman L, Alroy-Preis S, Ash N, Huppert A, Milo R. Protection against Covid-19 by BNT162b2 Booster across Age Groups. N Engl J Med. 2021 Dec 08; doi: 10.1056/NEJMoa2115926. Epub 2021 Dec 08. PMID: 34879188.
Copy Download .nbib Format: NLM
Protection against Covid-19 by BNT162b2 Booster across Age Groups.

The New England journal of medicine

Bar-On YM, Goldberg Y, Mandel M, Bodenheimer O, Freedman L, Alroy-Preis S, Ash N, Huppert A, Milo R.
PMID: 34879188
N Engl J Med. 2021 Dec 23;385(26):2421-2430. doi: 10.1056/NEJMoa2115926. Epub 2021 Dec 08.

BACKGROUND: After promising initial results from the administration of a third (booster) dose of the BNT162b2 messenger RNA vaccine (Pfizer-BioNTech) to persons 60 years of age or older, the booster campaign in Israel was gradually expanded to persons in...

Cite
Bar-On YM, Goldberg Y, Mandel M, et al. Protection against Covid-19 by BNT162b2 Booster across Age Groups. N Engl J Med. 2021;385(26):2421-2430doi: 10.1056/NEJMoa2115926.
Bar-On, Y. M., Goldberg, Y., Mandel, M., Bodenheimer, O., Freedman, L., Alroy-Preis, S., Ash, N., Huppert, A., & Milo, R. (2021). Protection against Covid-19 by BNT162b2 Booster across Age Groups. The New England journal of medicine, 385(26), 2421-2430. https://doi.org/10.1056/NEJMoa2115926
Bar-On, Yinon M, et al. "Protection against Covid-19 by BNT162b2 Booster across Age Groups." The New England journal of medicine vol. 385,26 (2021): 2421-2430. doi: https://doi.org/10.1056/NEJMoa2115926
Bar-On YM, Goldberg Y, Mandel M, Bodenheimer O, Freedman L, Alroy-Preis S, Ash N, Huppert A, Milo R. Protection against Covid-19 by BNT162b2 Booster across Age Groups. N Engl J Med. 2021 Dec 23;385(26):2421-2430. doi: 10.1056/NEJMoa2115926. Epub 2021 Dec 08. PMID: 34879188.
Copy Download .nbib Format: NLM
Severity of liver test abnormalities in coronavirus disease 2019 depends on comorbidities and predicts early in-hospital mortality.

European journal of gastroenterology & hepatology

Satapathy SK, Kuntzen C, Qiu H, Jiang Y, Bodenheimer HC, Roth NC, Lee TP, Hirsch JS, Trindade AJ, Bernstein DE.
PMID: 33560687
Eur J Gastroenterol Hepatol. 2021 Feb 05; doi: 10.1097/MEG.0000000000002055. Epub 2021 Feb 05.

BACKGROUND AND AIMS: Liver chemistry abnormalities (LCA) are common in patients with coronavirus disease 2019 (COVID-19), but their causes and clinical impact have not been adequately studied. We assessed the associations between LCA and clinical characteristics, inflammatory serum markers,...

Cite
Satapathy SK, Kuntzen C, Qiu H, et al. Severity of liver test abnormalities in coronavirus disease 2019 depends on comorbidities and predicts early in-hospital mortality. Eur J Gastroenterol Hepatol. 2021;doi: 10.1097/MEG.0000000000002055.
Satapathy, S. K., Kuntzen, C., Qiu, H., Jiang, Y., Bodenheimer, H. C., Roth, N. C., Lee, T. P., Hirsch, J. S., Trindade, A. J., Bernstein, D. E. (2021). Severity of liver test abnormalities in coronavirus disease 2019 depends on comorbidities and predicts early in-hospital mortality. European journal of gastroenterology & hepatology, . https://doi.org/10.1097/MEG.0000000000002055
Satapathy, Sanjaya K, et al. "Severity of liver test abnormalities in coronavirus disease 2019 depends on comorbidities and predicts early in-hospital mortality." European journal of gastroenterology & hepatology vol. (2021). doi: https://doi.org/10.1097/MEG.0000000000002055
Satapathy SK, Kuntzen C, Qiu H, Jiang Y, Bodenheimer HC, Roth NC, Lee TP, Hirsch JS, Trindade AJ, Bernstein DE. Severity of liver test abnormalities in coronavirus disease 2019 depends on comorbidities and predicts early in-hospital mortality. Eur J Gastroenterol Hepatol. 2021 Feb 05; doi: 10.1097/MEG.0000000000002055. Epub 2021 Feb 05. PMID: 33560687; PMCID: PMC8734572.
Copy Download .nbib Format: NLM
A STUDY OF PLASMA PROTEIN VARIATIONS IN SURGICAL PATIENTS.

Annals of surgery

Casten D, Bodenheimer M, Barcham I.
PMID: 17858167
Ann Surg. 1943 Jan;117(1):52-73. doi: 10.1097/00000658-194301000-00004.

No abstract available.

Cite
Casten D, Bodenheimer M, Barcham I. A STUDY OF PLASMA PROTEIN VARIATIONS IN SURGICAL PATIENTS. Ann Surg. 1943;117(1):52-73doi: 10.1097/00000658-194301000-00004.
Casten, D., Bodenheimer, M., & Barcham, I. (1943). A STUDY OF PLASMA PROTEIN VARIATIONS IN SURGICAL PATIENTS. Annals of surgery, 117(1), 52-73. https://doi.org/10.1097/00000658-194301000-00004
Casten, D, et al. "A STUDY OF PLASMA PROTEIN VARIATIONS IN SURGICAL PATIENTS." Annals of surgery vol. 117,1 (1943): 52-73. doi: https://doi.org/10.1097/00000658-194301000-00004
Casten D, Bodenheimer M, Barcham I. A STUDY OF PLASMA PROTEIN VARIATIONS IN SURGICAL PATIENTS. Ann Surg. 1943 Jan;117(1):52-73. doi: 10.1097/00000658-194301000-00004. PMID: 17858167; PMCID: PMC1617468.
Copy Download .nbib Format: NLM
The organization of health care.

JAMA

Grumbach K, Bodenheimer T.
PMID: 7799498
JAMA. 1995 Jan 11;273(2):160-7.

No abstract available.

Cite
Grumbach K, Bodenheimer T. The organization of health care. JAMA. 1995;273(2):160-7
Grumbach, K., & Bodenheimer, T. (1995). The organization of health care. JAMA, 273(2), 160-7.
Grumbach, K, and Bodenheimer, T. "The organization of health care." JAMA vol. 273,2 (1995): 160-7.
Grumbach K, Bodenheimer T. The organization of health care. JAMA. 1995 Jan 11;273(2):160-7. PMID: 7799498.
Copy Download .nbib Format: NLM
Immersive Virtual Reality for Visualization of Abdominal CT.

Proceedings of SPIE--the International Society for Optical Engineering

Lin Q, Xu Z, Li B, Baucom R, Poulose B, Landman BA, Bodenheimer RE.
PMID: 24386547
Proc SPIE Int Soc Opt Eng. 2013 Mar 28;8673. doi: 10.1117/12.2008050.

Immersive virtual environments use a stereoscopic head-mounted display and data glove to create high fidelity virtual experiences in which users can interact with three-dimensional models and perceive relationships at their true scale. This stands in stark contrast to traditional...

Cite
Lin Q, Xu Z, Li B, et al. Immersive Virtual Reality for Visualization of Abdominal CT. Proc SPIE Int Soc Opt Eng. 2013;8673doi: 10.1117/12.2008050.
Lin, Q., Xu, Z., Li, B., Baucom, R., Poulose, B., Landman, B. A., & Bodenheimer, R. E. (2013). Immersive Virtual Reality for Visualization of Abdominal CT. Proceedings of SPIE--the International Society for Optical Engineering, 8673. https://doi.org/10.1117/12.2008050
Lin, Qiufeng, et al. "Immersive Virtual Reality for Visualization of Abdominal CT." Proceedings of SPIE--the International Society for Optical Engineering vol. 8673 (2013). doi: https://doi.org/10.1117/12.2008050
Lin Q, Xu Z, Li B, Baucom R, Poulose B, Landman BA, Bodenheimer RE. Immersive Virtual Reality for Visualization of Abdominal CT. Proc SPIE Int Soc Opt Eng. 2013 Mar 28;8673. doi: 10.1117/12.2008050. PMID: 24386547; PMCID: PMC3877248.
Copy Download .nbib Format: NLM
Primary care: proposed solutions to the physician shortage without training more physicians.

Health affairs (Project Hope)

Bodenheimer TS, Smith MD.
PMID: 24191075
Health Aff (Millwood). 2013 Nov;32(11):1881-6. doi: 10.1377/hlthaff.2013.0234.

The adult primary care "physician shortage" is more accurately portrayed as a gap between the adult population's demand for primary care services and the capacity of primary care, as currently delivered, to meet that demand. Given current trends, producing...

Cite
Bodenheimer TS, Smith MD. Primary care: proposed solutions to the physician shortage without training more physicians. Health Aff (Millwood). 2013;32(11):1881-6doi: 10.1377/hlthaff.2013.0234.
Bodenheimer, T. S., & Smith, M. D. (2013). Primary care: proposed solutions to the physician shortage without training more physicians. Health affairs (Project Hope), 32(11), 1881-6. https://doi.org/10.1377/hlthaff.2013.0234
Bodenheimer, Thomas S, and Smith, Mark D. "Primary care: proposed solutions to the physician shortage without training more physicians." Health affairs (Project Hope) vol. 32,11 (2013): 1881-6. doi: https://doi.org/10.1377/hlthaff.2013.0234
Bodenheimer TS, Smith MD. Primary care: proposed solutions to the physician shortage without training more physicians. Health Aff (Millwood). 2013 Nov;32(11):1881-6. doi: 10.1377/hlthaff.2013.0234. PMID: 24191075.
Copy Download .nbib Format: NLM
Protection against Covid-19 by BNT162b2 Booster across Age Groups.

The New England journal of medicine

Bar-On YM, Goldberg Y, Mandel M, Bodenheimer O, Freedman L, Alroy-Preis S, Ash N, Huppert A, Milo R.
PMID: 34879188
N Engl J Med. 2021 Dec 23;385(26):2421-2430. doi: 10.1056/NEJMoa2115926. Epub 2021 Dec 08.

BACKGROUND: After promising initial results from the administration of a third (booster) dose of the BNT162b2 messenger RNA vaccine (Pfizer-BioNTech) to persons 60 years of age or older, the booster campaign in Israel was gradually expanded to persons in...

Cite
Bar-On YM, Goldberg Y, Mandel M, et al. Protection against Covid-19 by BNT162b2 Booster across Age Groups. N Engl J Med. 2021;385(26):2421-2430doi: 10.1056/NEJMoa2115926.
Bar-On, Y. M., Goldberg, Y., Mandel, M., Bodenheimer, O., Freedman, L., Alroy-Preis, S., Ash, N., Huppert, A., & Milo, R. (2021). Protection against Covid-19 by BNT162b2 Booster across Age Groups. The New England journal of medicine, 385(26), 2421-2430. https://doi.org/10.1056/NEJMoa2115926
Bar-On, Yinon M, et al. "Protection against Covid-19 by BNT162b2 Booster across Age Groups." The New England journal of medicine vol. 385,26 (2021): 2421-2430. doi: https://doi.org/10.1056/NEJMoa2115926
Bar-On YM, Goldberg Y, Mandel M, Bodenheimer O, Freedman L, Alroy-Preis S, Ash N, Huppert A, Milo R. Protection against Covid-19 by BNT162b2 Booster across Age Groups. N Engl J Med. 2021 Dec 23;385(26):2421-2430. doi: 10.1056/NEJMoa2115926. Epub 2021 Dec 08. PMID: 34879188.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 38 entries